{
  "experiment_id": "d34206b9ee9393e68b5b31124cb5d261",
  "task_name": "broadening_of_narrow_synonyms",
  "task_hash": "a2c885aa2a82bb5b150f213062bbeb89",
  "model_id": "us.anthropic.claude-3-5-sonnet-20240620-v1:0",
  "system_instructions": "You are a metadata curation assistant. Your task is to help improve and correct metadata \naccording to the specific instructions provided for each task. Be precise, accurate, and \nfollow the guidelines carefully.\n",
  "temperature": 0.0,
  "thinking": false,
  "tools": [],
  "timestamp": "2025-12-11T03:09:35.578296",
  "task_result": {
    "task_name": "broadening_of_narrow_synonyms",
    "num_samples": 10,
    "results": [
      {
        "sample_index": 0,
        "input": {
          "diagnosis": "Neurofibromatosis type 1 microdeletion syndrome",
          "assay": "clinical whole-exome sequencing",
          "tumorType": "Plexiform neurofibroma (morphologic abnormality)"
        },
        "response": {
          "success": true,
          "content": "Here is the corrected metadata with broadened terms that match the controlled terminology in the Target Schema:\n\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Plexiform Neurofibroma\"\n}\n\nExplanations for the changes:\n\n1. \"diagnosis\": \"Neurofibromatosis type 1 microdeletion syndrome\" was broadened to \"Neurofibromatosis type 1\", which is an exact match to one of the enumerated values in the Target Schema.\n\n2. \"assay\": \"clinical whole-exome sequencing\" was broadened to \"whole exome sequencing\", which is an exact match to one of the enumerated values in the Target Schema.\n\n3. \"tumorType\": \"Plexiform neurofibroma (morphologic abnormality)\" was simplified to \"Plexiform Neurofibroma\", which is an exact match to one of the enumerated values in the Target Schema. The capitalization was also adjusted to match the schema.\n\nThese changes ensure that all values match the controlled terminology specified in the Target Schema while broadening overly specific terms.",
          "model_id": "us.anthropic.claude-3-5-sonnet-20240620-v1:0",
          "usage": {
            "input_tokens": 3052,
            "output_tokens": 274
          },
          "attempt": 1,
          "raw_response": {
            "id": "msg_bdrk_01BZstu7xEPv44Bry6hiCSWx",
            "type": "message",
            "role": "assistant",
            "model": "claude-3-5-sonnet-20240620",
            "content": [
              {
                "type": "text",
                "text": "Here is the corrected metadata with broadened terms that match the controlled terminology in the Target Schema:\n\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Plexiform Neurofibroma\"\n}\n\nExplanations for the changes:\n\n1. \"diagnosis\": \"Neurofibromatosis type 1 microdeletion syndrome\" was broadened to \"Neurofibromatosis type 1\", which is an exact match to one of the enumerated values in the Target Schema.\n\n2. \"assay\": \"clinical whole-exome sequencing\" was broadened to \"whole exome sequencing\", which is an exact match to one of the enumerated values in the Target Schema.\n\n3. \"tumorType\": \"Plexiform neurofibroma (morphologic abnormality)\" was simplified to \"Plexiform Neurofibroma\", which is an exact match to one of the enumerated values in the Target Schema. The capitalization was also adjusted to match the schema.\n\nThese changes ensure that all values match the controlled terminology specified in the Target Schema while broadening overly specific terms."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3052,
              "output_tokens": 274
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "whole exome sequencing",
          "tumorType": "Plexiform Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 3052,
          "output_tokens": 274,
          "total_tokens": 3326
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 1,
        "input": {
          "diagnosis": "Neurofibromatosis type 1 with optic pathway glioma",
          "assay": "Illumina whole exome sequencing ",
          "tumorType": "malignant triton tumor"
        },
        "response": {
          "success": true,
          "content": "Here is the corrected metadata with broadened terms that match the controlled terminology in the Target Schema:\n\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n\nExplanations for the changes:\n\n1. \"diagnosis\": Changed from \"Neurofibromatosis type 1 with optic pathway glioma\" to \"Neurofibromatosis type 1\". The optic pathway glioma is a specific manifestation of NF1, but the broader diagnosis term is used as per the schema.\n\n2. \"assay\": Changed from \"Illumina whole exome sequencing\" to \"whole exome sequencing\". The brand name (Illumina) was removed to use the more general term that matches the schema.\n\n3. \"tumorType\": Changed from \"malignant triton tumor\" to \"Malignant Peripheral Nerve Sheath Tumor\". A malignant triton tumor is a specific type of Malignant Peripheral Nerve Sheath Tumor (MPNST), but the broader term is used as it's the closest match in the provided schema.",
          "model_id": "us.anthropic.claude-3-5-sonnet-20240620-v1:0",
          "usage": {
            "input_tokens": 3047,
            "output_tokens": 287
          },
          "attempt": 1,
          "raw_response": {
            "id": "msg_bdrk_01VZaMU6thfXjJtpDcWwMeVq",
            "type": "message",
            "role": "assistant",
            "model": "claude-3-5-sonnet-20240620",
            "content": [
              {
                "type": "text",
                "text": "Here is the corrected metadata with broadened terms that match the controlled terminology in the Target Schema:\n\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n\nExplanations for the changes:\n\n1. \"diagnosis\": Changed from \"Neurofibromatosis type 1 with optic pathway glioma\" to \"Neurofibromatosis type 1\". The optic pathway glioma is a specific manifestation of NF1, but the broader diagnosis term is used as per the schema.\n\n2. \"assay\": Changed from \"Illumina whole exome sequencing\" to \"whole exome sequencing\". The brand name (Illumina) was removed to use the more general term that matches the schema.\n\n3. \"tumorType\": Changed from \"malignant triton tumor\" to \"Malignant Peripheral Nerve Sheath Tumor\". A malignant triton tumor is a specific type of Malignant Peripheral Nerve Sheath Tumor (MPNST), but the broader term is used as it's the closest match in the provided schema."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3047,
              "output_tokens": 287
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "whole exome sequencing",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
        },
        "token_usage": {
          "input_tokens": 3047,
          "output_tokens": 287,
          "total_tokens": 3334
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 2,
        "input": {
          "diagnosis": "Watson Syndrome",
          "assay": "MGI whole genome sequencing",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation"
        },
        "response": {
          "success": true,
          "content": "I'll broaden the narrow synonyms in the provided metadata to match the controlled terminology in the Target Schema. Here's the corrected metadata:\n\n{\n  \"diagnosis\": \"Noonan Syndrome\",\n  \"assay\": \"whole genome sequencing\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n\nExplanations for the changes:\n\n1. \"diagnosis\": \"Watson Syndrome\" was changed to \"Noonan Syndrome\". Watson Syndrome is considered a variant of Noonan Syndrome, so we broadened it to the more general term available in the Target Schema.\n\n2. \"assay\": \"MGI whole genome sequencing\" was changed to \"whole genome sequencing\". The specific platform (MGI) was removed to match the broader term available in the Target Schema.\n\n3. \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation\" was changed to \"Malignant Peripheral Nerve Sheath Tumor\". The specific subtype information was removed to match the broader term available in the Target Schema.\n\nThese changes ensure that the metadata uses the exact controlled terminology values from the Target Schema as required.",
          "model_id": "us.anthropic.claude-3-5-sonnet-20240620-v1:0",
          "usage": {
            "input_tokens": 3046,
            "output_tokens": 276
          },
          "attempt": 1,
          "raw_response": {
            "id": "msg_bdrk_01WsVfA7q8wXPyfU8vwK8zgs",
            "type": "message",
            "role": "assistant",
            "model": "claude-3-5-sonnet-20240620",
            "content": [
              {
                "type": "text",
                "text": "I'll broaden the narrow synonyms in the provided metadata to match the controlled terminology in the Target Schema. Here's the corrected metadata:\n\n{\n  \"diagnosis\": \"Noonan Syndrome\",\n  \"assay\": \"whole genome sequencing\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n\nExplanations for the changes:\n\n1. \"diagnosis\": \"Watson Syndrome\" was changed to \"Noonan Syndrome\". Watson Syndrome is considered a variant of Noonan Syndrome, so we broadened it to the more general term available in the Target Schema.\n\n2. \"assay\": \"MGI whole genome sequencing\" was changed to \"whole genome sequencing\". The specific platform (MGI) was removed to match the broader term available in the Target Schema.\n\n3. \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation\" was changed to \"Malignant Peripheral Nerve Sheath Tumor\". The specific subtype information was removed to match the broader term available in the Target Schema.\n\nThese changes ensure that the metadata uses the exact controlled terminology values from the Target Schema as required."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3046,
              "output_tokens": 276
            }
          }
        },
        "score": 0.6666666666666666,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "whole genome sequencing",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
        },
        "token_usage": {
          "input_tokens": 3046,
          "output_tokens": 276,
          "total_tokens": 3322
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 3,
        "input": {
          "diagnosis": "neurofibromatosis, familial spinal",
          "assay": "open MRI",
          "tumorType": "unknown - no information available"
        },
        "response": {
          "success": true,
          "content": "Here is the corrected metadata with broadened terms that match the controlled terminology in the Target Schema:\n\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"conventional MRI\",\n  \"tumorType\": \"Unknown\"\n}\n\nExplanations for the changes:\n1. \"neurofibromatosis, familial spinal\" was broadened to \"Neurofibromatosis type 1\", which is the closest match in the provided enum list for diagnosis.\n2. \"open MRI\" was broadened to \"conventional MRI\", which is the most appropriate match in the assay enum list.\n3. \"unknown - no information available\" was simplified to \"Unknown\", which is the exact match in the tumorType enum list.",
          "model_id": "us.anthropic.claude-3-5-sonnet-20240620-v1:0",
          "usage": {
            "input_tokens": 3034,
            "output_tokens": 177
          },
          "attempt": 1,
          "raw_response": {
            "id": "msg_bdrk_01LEVqBqpag8mbQcLDrukoVL",
            "type": "message",
            "role": "assistant",
            "model": "claude-3-5-sonnet-20240620",
            "content": [
              {
                "type": "text",
                "text": "Here is the corrected metadata with broadened terms that match the controlled terminology in the Target Schema:\n\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"conventional MRI\",\n  \"tumorType\": \"Unknown\"\n}\n\nExplanations for the changes:\n1. \"neurofibromatosis, familial spinal\" was broadened to \"Neurofibromatosis type 1\", which is the closest match in the provided enum list for diagnosis.\n2. \"open MRI\" was broadened to \"conventional MRI\", which is the most appropriate match in the assay enum list.\n3. \"unknown - no information available\" was simplified to \"Unknown\", which is the exact match in the tumorType enum list."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3034,
              "output_tokens": 177
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "conventional MRI",
          "tumorType": "Unknown"
        },
        "token_usage": {
          "input_tokens": 3034,
          "output_tokens": 177,
          "total_tokens": 3211
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 4,
        "input": {
          "diagnosis": "Not Applicable",
          "assay": "immunohistochemistry of skin",
          "tumorType": "Cutaneous storiform neurofibroma"
        },
        "response": {
          "success": true,
          "content": "Here is the corrected metadata with broadened terms that match the controlled terminology in the Target Schema:\n\n{\n  \"diagnosis\": \"Not Applicable\",\n  \"assay\": \"immunohistochemistry\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n\nChanges made:\n1. \"diagnosis\" was already correct, so no change was needed.\n2. \"assay\" was broadened from \"immunohistochemistry of skin\" to simply \"immunohistochemistry\" to match the controlled terminology.\n3. \"tumorType\" was changed from \"Cutaneous storiform neurofibroma\" to \"Cutaneous Neurofibroma\" to match the exact term in the schema's enumerated list.",
          "model_id": "us.anthropic.claude-3-5-sonnet-20240620-v1:0",
          "usage": {
            "input_tokens": 3034,
            "output_tokens": 168
          },
          "attempt": 1,
          "raw_response": {
            "id": "msg_bdrk_01SS1Fd74tuP2g27vDEXo2Lv",
            "type": "message",
            "role": "assistant",
            "model": "claude-3-5-sonnet-20240620",
            "content": [
              {
                "type": "text",
                "text": "Here is the corrected metadata with broadened terms that match the controlled terminology in the Target Schema:\n\n{\n  \"diagnosis\": \"Not Applicable\",\n  \"assay\": \"immunohistochemistry\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n\nChanges made:\n1. \"diagnosis\" was already correct, so no change was needed.\n2. \"assay\" was broadened from \"immunohistochemistry of skin\" to simply \"immunohistochemistry\" to match the controlled terminology.\n3. \"tumorType\" was changed from \"Cutaneous storiform neurofibroma\" to \"Cutaneous Neurofibroma\" to match the exact term in the schema's enumerated list."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3034,
              "output_tokens": 168
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Not Applicable",
          "assay": "immunohistochemistry",
          "tumorType": "Cutaneous Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 3034,
          "output_tokens": 168,
          "total_tokens": 3202
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 5,
        "input": {
          "diagnosis": "chromosome 17q11.2 deletion syndrome, 1.4Mb",
          "assay": "cell viability assay using Annexin V staining",
          "tumorType": "Pedunculated Cutaneous Neurofibroma"
        },
        "response": {
          "success": true,
          "content": "Here is the corrected metadata with broadened terms that match the controlled terminology in the Target Schema:\n\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"cell viability assay\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n\nExplanations for the changes:\n\n1. \"diagnosis\": \"chromosome 17q11.2 deletion syndrome, 1.4Mb\" was broadened to \"Neurofibromatosis type 1\", which is the standard term for this condition in the provided schema.\n\n2. \"assay\": \"cell viability assay using Annexin V staining\" was broadened to \"cell viability assay\", which is the exact term listed in the schema's controlled vocabulary.\n\n3. \"tumorType\": \"Pedunculated Cutaneous Neurofibroma\" was broadened to \"Cutaneous Neurofibroma\", which is the standard term available in the schema for this type of tumor.",
          "model_id": "us.anthropic.claude-3-5-sonnet-20240620-v1:0",
          "usage": {
            "input_tokens": 3056,
            "output_tokens": 232
          },
          "attempt": 1,
          "raw_response": {
            "id": "msg_bdrk_01VCAQMpX6rePx9j7Q2AUnDS",
            "type": "message",
            "role": "assistant",
            "model": "claude-3-5-sonnet-20240620",
            "content": [
              {
                "type": "text",
                "text": "Here is the corrected metadata with broadened terms that match the controlled terminology in the Target Schema:\n\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"cell viability assay\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n\nExplanations for the changes:\n\n1. \"diagnosis\": \"chromosome 17q11.2 deletion syndrome, 1.4Mb\" was broadened to \"Neurofibromatosis type 1\", which is the standard term for this condition in the provided schema.\n\n2. \"assay\": \"cell viability assay using Annexin V staining\" was broadened to \"cell viability assay\", which is the exact term listed in the schema's controlled vocabulary.\n\n3. \"tumorType\": \"Pedunculated Cutaneous Neurofibroma\" was broadened to \"Cutaneous Neurofibroma\", which is the standard term available in the schema for this type of tumor."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3056,
              "output_tokens": 232
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "cell viability assay",
          "tumorType": "Cutaneous Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 3056,
          "output_tokens": 232,
          "total_tokens": 3288
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 6,
        "input": {
          "diagnosis": "Neurofibromatosis type 1 with scoliosis",
          "assay": "anti-tag immunocytochemistry",
          "tumorType": "sessile cutaneous neurofibroma"
        },
        "response": {
          "success": true,
          "content": "Here is the corrected metadata with broadened terms that match the controlled terminology in the Target Schema:\n\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"immunocytochemistry\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n\nExplanations for the changes:\n1. \"diagnosis\": Changed from \"Neurofibromatosis type 1 with scoliosis\" to \"Neurofibromatosis type 1\" to match the exact enum value in the schema. The specific symptom (scoliosis) was removed as it's not part of the controlled terminology.\n2. \"assay\": Broadened from \"anti-tag immunocytochemistry\" to \"immunocytochemistry\" to match the exact enum value in the schema. The specific type of immunocytochemistry was removed.\n3. \"tumorType\": Changed from \"sessile cutaneous neurofibroma\" to \"Cutaneous Neurofibroma\" to match the exact enum value in the schema. The specific descriptor (sessile) was removed as it's not part of the controlled terminology.",
          "model_id": "us.anthropic.claude-3-5-sonnet-20240620-v1:0",
          "usage": {
            "input_tokens": 3047,
            "output_tokens": 264
          },
          "attempt": 1,
          "raw_response": {
            "id": "msg_bdrk_0141uV4zEUA3CzEy1ocDimQc",
            "type": "message",
            "role": "assistant",
            "model": "claude-3-5-sonnet-20240620",
            "content": [
              {
                "type": "text",
                "text": "Here is the corrected metadata with broadened terms that match the controlled terminology in the Target Schema:\n\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"immunocytochemistry\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n\nExplanations for the changes:\n1. \"diagnosis\": Changed from \"Neurofibromatosis type 1 with scoliosis\" to \"Neurofibromatosis type 1\" to match the exact enum value in the schema. The specific symptom (scoliosis) was removed as it's not part of the controlled terminology.\n2. \"assay\": Broadened from \"anti-tag immunocytochemistry\" to \"immunocytochemistry\" to match the exact enum value in the schema. The specific type of immunocytochemistry was removed.\n3. \"tumorType\": Changed from \"sessile cutaneous neurofibroma\" to \"Cutaneous Neurofibroma\" to match the exact enum value in the schema. The specific descriptor (sessile) was removed as it's not part of the controlled terminology."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3047,
              "output_tokens": 264
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "immunocytochemistry",
          "tumorType": "Cutaneous Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 3047,
          "output_tokens": 264,
          "total_tokens": 3311
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 7,
        "input": {
          "diagnosis": "neurofibromatosis, peripheral type",
          "assay": "wide bore MRI",
          "tumorType": "no clear diagnosis"
        },
        "response": {
          "success": true,
          "content": "Here is the corrected metadata with broadened terms that match the controlled terminology in the Target Schema:\n\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"conventional MRI\",\n  \"tumorType\": \"Unknown\"\n}\n\nExplanations for the changes:\n\n1. \"diagnosis\": \"neurofibromatosis, peripheral type\" was broadened to \"Neurofibromatosis type 1\", which is the standard term in the schema for this condition.\n\n2. \"assay\": \"wide bore MRI\" was broadened to \"conventional MRI\", which is the closest matching term in the schema for this type of imaging.\n\n3. \"tumorType\": \"no clear diagnosis\" was changed to \"Unknown\", as this is the most appropriate term from the schema when there is no clear tumor type identified.",
          "model_id": "us.anthropic.claude-3-5-sonnet-20240620-v1:0",
          "usage": {
            "input_tokens": 3031,
            "output_tokens": 193
          },
          "attempt": 1,
          "raw_response": {
            "id": "msg_bdrk_01GfdrFyoseSeEFWvW8qABZD",
            "type": "message",
            "role": "assistant",
            "model": "claude-3-5-sonnet-20240620",
            "content": [
              {
                "type": "text",
                "text": "Here is the corrected metadata with broadened terms that match the controlled terminology in the Target Schema:\n\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"conventional MRI\",\n  \"tumorType\": \"Unknown\"\n}\n\nExplanations for the changes:\n\n1. \"diagnosis\": \"neurofibromatosis, peripheral type\" was broadened to \"Neurofibromatosis type 1\", which is the standard term in the schema for this condition.\n\n2. \"assay\": \"wide bore MRI\" was broadened to \"conventional MRI\", which is the closest matching term in the schema for this type of imaging.\n\n3. \"tumorType\": \"no clear diagnosis\" was changed to \"Unknown\", as this is the most appropriate term from the schema when there is no clear tumor type identified."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3031,
              "output_tokens": 193
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "conventional MRI",
          "tumorType": "Unknown"
        },
        "token_usage": {
          "input_tokens": 3031,
          "output_tokens": 193,
          "total_tokens": 3224
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 8,
        "input": {
          "diagnosis": "acoustic neurofibromatosis",
          "assay": "RNA-seq with ribosomal RNA depletion",
          "tumorType": "Acoustic neuroma of left vestibular nerve"
        },
        "response": {
          "success": true,
          "content": "Here is the corrected metadata with broadened terms that match the controlled terminology in the Target Schema:\n\n{\n  \"diagnosis\": \"NF2-related schwannomatosis\",\n  \"assay\": \"RNA-seq\",\n  \"tumorType\": \"Schwannoma\"\n}\n\nExplanations for the changes:\n\n1. \"diagnosis\": \"acoustic neurofibromatosis\" was broadened to \"NF2-related schwannomatosis\", which is the closest match in the provided enum list for diagnosis.\n\n2. \"assay\": \"RNA-seq with ribosomal RNA depletion\" was simplified to \"RNA-seq\", as the more specific details about ribosomal RNA depletion are not included in the enum list for assay.\n\n3. \"tumorType\": \"Acoustic neuroma of left vestibular nerve\" was broadened to \"Schwannoma\", which is the closest match in the provided enum list for tumorType. An acoustic neuroma is a type of schwannoma.\n\nThese changes ensure that the metadata uses the exact controlled terminology values from the Target Schema as required.",
          "model_id": "us.anthropic.claude-3-5-sonnet-20240620-v1:0",
          "usage": {
            "input_tokens": 3044,
            "output_tokens": 249
          },
          "attempt": 1,
          "raw_response": {
            "id": "msg_bdrk_015rDpaNyPZ3bSZptVBkjPeK",
            "type": "message",
            "role": "assistant",
            "model": "claude-3-5-sonnet-20240620",
            "content": [
              {
                "type": "text",
                "text": "Here is the corrected metadata with broadened terms that match the controlled terminology in the Target Schema:\n\n{\n  \"diagnosis\": \"NF2-related schwannomatosis\",\n  \"assay\": \"RNA-seq\",\n  \"tumorType\": \"Schwannoma\"\n}\n\nExplanations for the changes:\n\n1. \"diagnosis\": \"acoustic neurofibromatosis\" was broadened to \"NF2-related schwannomatosis\", which is the closest match in the provided enum list for diagnosis.\n\n2. \"assay\": \"RNA-seq with ribosomal RNA depletion\" was simplified to \"RNA-seq\", as the more specific details about ribosomal RNA depletion are not included in the enum list for assay.\n\n3. \"tumorType\": \"Acoustic neuroma of left vestibular nerve\" was broadened to \"Schwannoma\", which is the closest match in the provided enum list for tumorType. An acoustic neuroma is a type of schwannoma.\n\nThese changes ensure that the metadata uses the exact controlled terminology values from the Target Schema as required."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3044,
              "output_tokens": 249
            }
          }
        },
        "score": 0.6666666666666666,
        "ground_truth": {
          "diagnosis": "NF2-related schwannomatosis",
          "assay": "RNA-seq",
          "tumorType": "schwannoma"
        },
        "token_usage": {
          "input_tokens": 3044,
          "output_tokens": 249,
          "total_tokens": 3293
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 9,
        "input": {
          "diagnosis": "neurofibromatosis type 1 due to NF1 mutation or intragenic deletion",
          "assay": "CellTiter-Glo\u00ae 3D Cell Viability Assay",
          "tumorType": "Epithelioid Malignant Peripheral Nerve Sheath Tumor"
        },
        "response": {
          "success": true,
          "content": "Here is the corrected metadata with broadened terms that match the controlled terminology in the Target Schema:\n\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"3D microtissue viability\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n\nExplanations for the changes:\n\n1. \"diagnosis\": The specific \"neurofibromatosis type 1 due to NF1 mutation or intragenic deletion\" was broadened to the more general term \"Neurofibromatosis type 1\" which is an exact match from the schema's enumerated values.\n\n2. \"assay\": The \"CellTiter-Glo\u00ae 3D Cell Viability Assay\" was broadened to \"3D microtissue viability\", which is the closest match from the schema's enumerated values for assays that measure 3D cell viability.\n\n3. \"tumorType\": \"Epithelioid Malignant Peripheral Nerve Sheath Tumor\" was broadened to \"Malignant Peripheral Nerve Sheath Tumor\", which is an exact match from the schema's enumerated values. The schema does not include a specific entry for the epithelioid subtype.",
          "model_id": "us.anthropic.claude-3-5-sonnet-20240620-v1:0",
          "usage": {
            "input_tokens": 3077,
            "output_tokens": 299
          },
          "attempt": 1,
          "raw_response": {
            "id": "msg_bdrk_01M9fPGe1duMKUzRhSJ9fenj",
            "type": "message",
            "role": "assistant",
            "model": "claude-3-5-sonnet-20240620",
            "content": [
              {
                "type": "text",
                "text": "Here is the corrected metadata with broadened terms that match the controlled terminology in the Target Schema:\n\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"3D microtissue viability\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n\nExplanations for the changes:\n\n1. \"diagnosis\": The specific \"neurofibromatosis type 1 due to NF1 mutation or intragenic deletion\" was broadened to the more general term \"Neurofibromatosis type 1\" which is an exact match from the schema's enumerated values.\n\n2. \"assay\": The \"CellTiter-Glo\u00ae 3D Cell Viability Assay\" was broadened to \"3D microtissue viability\", which is the closest match from the schema's enumerated values for assays that measure 3D cell viability.\n\n3. \"tumorType\": \"Epithelioid Malignant Peripheral Nerve Sheath Tumor\" was broadened to \"Malignant Peripheral Nerve Sheath Tumor\", which is an exact match from the schema's enumerated values. The schema does not include a specific entry for the epithelioid subtype."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3077,
              "output_tokens": 299
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "3D microtissue viability",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
        },
        "token_usage": {
          "input_tokens": 3077,
          "output_tokens": 299,
          "total_tokens": 3376
        },
        "tool_calls": [],
        "tool_execution_history": []
      }
    ],
    "metrics": {
      "total_samples": 10,
      "successful_runs": 10,
      "failed_runs": 0,
      "success_rate": 1.0,
      "average_score": 0.9333333333333332,
      "min_score": 0.6666666666666666,
      "max_score": 1.0,
      "num_scored": 10
    },
    "duration_seconds": 68.14265298843384,
    "token_usage": {
      "input_tokens": 30468,
      "output_tokens": 2419,
      "total_tokens": 32887
    }
  }
}